Trastuzumab alters the expression of genes essential for cardiac function and induces ultrastructural changes of cardiomyocytes in mice.
about
Twenty years of anti-HER2 therapy-associated cardiotoxicityThe role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitorsAn update on cardio-oncology.Drug-induced mitochondrial dysfunction and cardiotoxicity.The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update.Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC-derived cardiomyocytes.EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology.Alternative Biomarkers for Combined Biology.Principles of a risk evaluation and mitigation strategy (REMS) for breast cancer patients receiving potentially cardiotoxic adjuvant treatments.Trastuzumab cardiotoxicity: from clinical trials to experimental studies.Interactions Between Therapeutic Proteins and Small Molecules: The Shared Role of Perpetrators and Victims.Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab.Role of TFEB Mediated Autophagy, Oxidative Stress, Inflammation, and Cell Death in Endotoxin Induced Myocardial Toxicity of Young and Aged Mice.Apigenin Alleviates Endotoxin-Induced Myocardial Toxicity by Modulating Inflammation, Oxidative Stress, and AutophagyHow does trastuzumab treatment affect the right ventricle in females with breast cancer?Incidence, Diagnosis, and Treatment of Cardiac Toxicity from Trastuzumab in Patients with Breast Cancer.Type IIB DNA topoisomerase is downregulated by trastuzumab and doxorubicin to synergize cardiotoxicity.Protecting the heart in cancer therapyAnticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related MechanismsTrastuzumab-mediated cardiotoxicity: current understanding, challenges, and frontiers
P2860
Q28079391-FE13CBFA-E41D-422C-810E-F93804E5100CQ28081504-CB912709-7B4D-48E3-88E3-165C0296153BQ34650059-3DF6D278-993B-4C8A-A5C1-7E9EA718AC7EQ36339445-2465B1E8-E0CA-4A37-896E-16615ECE0FC7Q36683248-C08FD91B-3CC1-4B6D-9FE2-7D86C9F00EF3Q37131070-6FD7C144-B867-4748-B5B0-A61C07ACAABEQ37592520-FD9C4C5B-9E40-44C6-A084-5CF9EA265EF6Q38368230-CF816AA9-20E3-43A7-B1AC-51E037920E5BQ38747992-BB69859B-D969-47B2-A64A-4565CD4A282BQ38786052-31ECF373-A679-4388-B0D3-E145ED15681DQ38974785-13AB3274-F2E3-425B-B964-195C97B1F132Q39047005-7208A8AD-6339-464B-9481-DD6F75C768CAQ39344380-8BB2EDD7-1E7F-4D37-9B71-6E6793AAD336Q41008644-67DE87AA-9CE4-439B-B8F0-9C560F9A74E3Q41371118-EE16FC0B-4FEB-4B97-9127-3464FD423FDDQ42318401-86331BCC-EA3D-4ADB-9CEA-41B436D0E1DDQ49961375-30DE055D-32B8-4B2F-91B4-00E260B03F99Q50060140-73C9199E-0C07-4F01-805C-D254FF3299A4Q57821006-86094A25-0771-4332-8535-5AC9B4E89CDBQ58554222-F67A0DED-A9C2-4B2C-B52D-2D58833E7D0FQ58780288-C8B52EC7-C6DE-4CCA-BE1C-3A04A12E3EEC
P2860
Trastuzumab alters the expression of genes essential for cardiac function and induces ultrastructural changes of cardiomyocytes in mice.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Trastuzumab alters the express ...... ges of cardiomyocytes in mice.
@en
type
label
Trastuzumab alters the express ...... ges of cardiomyocytes in mice.
@en
prefLabel
Trastuzumab alters the express ...... ges of cardiomyocytes in mice.
@en
P2093
P2860
P1433
P1476
Trastuzumab alters the express ...... ges of cardiomyocytes in mice.
@en
P2093
Dianne S Hirsch
M Khair ElZarrad
Milos Dokmanovic
Nishant Mohan
Partha Mukhopadhyay
Wen Jin Wu
P2860
P304
P356
10.1371/JOURNAL.PONE.0079543
P407
P50
P577
2013-11-08T00:00:00Z